LQDA Liquidia Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: LQDA

Price (delayed)

$61.67

Market cap

$5.48B

P/E Ratio

256.96

Dividend/share

N/A

EPS

$0.24

Enterprise value

$5.44B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 98

Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT technology. The Company operates through two subsidiaries, ...

Highlights
LQDA's equity has surged by 143% since the previous quarter and by 118% year-on-year
LQDA's net income has soared by 132% from the previous quarter and by 116% YoY
The quick ratio is down by 29% YoY but it is up by 10% QoQ
The company's debt rose by 25% YoY but it fell by 7% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://liquidia.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of LQDA

LQDA stock price

How has the Liquidia stock price performed over time
Intraday
10.74%
1 week
-0.58%
1 month
60.27%
1 year
250.4%
YTD
78.81%
QTD
63.41%

Financial performance

How have Liquidia's revenue and profit performed over time
Revenue
$288.07M
Gross profit
$264.49M
Operating income
$45.55M
Net income
$22.31M
Gross margin
91.8%
Net margin
7.7%
LQDA's operating income has surged by 189% since the previous quarter and by 136% year-on-year
The company's operating margin has surged by 149% QoQ and by 102% YoY
LQDA's net income has soared by 132% from the previous quarter and by 116% YoY
The company's net margin has surged by 118% QoQ and by 101% YoY

Price vs fundamentals

How does LQDA's price correlate with its fundamentals

Growth

What is Liquidia's growth rate over time

Valuation

What is Liquidia stock price valuation
P/E
256.96
P/B
50.05
P/S
18.84
EV/EBIT
104.22
EV/EBITDA
101.6
EV/Sales
18.89
Liquidia's EPS has surged by 130% QoQ and by 114% YoY
LQDA's equity has surged by 143% since the previous quarter and by 118% year-on-year
The stock's P/B is 129% above its 5-year quarterly average of 19.7 but 30% below its last 4 quarters average of 64.1
LQDA's revenue has soared by 82% QoQ
The stock's price to sales (P/S) is 53% less than its 5-year quarterly average of 36.2 and 40% less than its last 4 quarters average of 28.5

Efficiency

How efficient is Liquidia business performance
Liquidia's return on sales has surged by 164% QoQ and by 102% YoY
The ROA has soared by 128% from the previous quarter and by 112% YoY
The ROIC has soared by 127% YoY
The ROE has soared by 126% YoY and by 122% from the previous quarter

Dividends

What is LQDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LQDA.

Financial health

How did Liquidia financials performed over time
The total assets is 37% more than the total liabilities
The total assets has soared by 77% YoY and by 22% from the previous quarter
The company's total liabilities has surged by 65% YoY and by 3.4% QoQ
The company's debt is 70% higher than its equity
LQDA's equity has surged by 143% since the previous quarter and by 118% year-on-year
The debt to equity has plunged by 62% from the previous quarter and by 43% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.